EWTX Insider Transactions
| Transaction Date (SEC Report ) |
Reporting Name | Relationship | Shrs. Owned | Type | Acq./Disp. | Shrs. Transacted | Price() | Amount() |
|---|---|---|---|---|---|---|---|---|
| 2023-03-03 | Fox Jonathan C | 43,731 | A-Award | A | 43,731 | 9.43 | 412,383.33 | |
| 2023-03-02 | Fox Jonathan C | 0 | 0 | 0.00 | 0.00 | |||
| 2022-12-30 | Semigran Marc | director: Chief Development Officer | 300,000 | A-Award | A | 300,000 | 0.00 | 0.00 |
| 2022-12-19 | Semigran Marc | None | 0 | None | None | 0.00 | ||
| 2022-12-19 | Semigran Marc | 0 | 0 | 0.00 | 0.00 | |||
| 2022-10-03 | MOORE JOHN R | director: General Counsel | 122,997 | M-Exempt | D | 4,730 | 0.00 | 0.00 |
| 2022-10-03 | MOORE JOHN R | director: General Counsel | 7,730 | M-Exempt | A | 4,730 | 1.93 | 9,128.90 |
| 2022-10-03 | MOORE JOHN R | director: General Counsel | 3,000 | S-Sale | D | 4,730 | 9.76 | 46,154.87 |
| 2022-09-16 | Thompson Peter A. | director, 10 percent owner: | 13,981,952 | P-Purchase | A | 484,496 | 10.32 | 4,999,998.72 |
| 2022-09-16 | ORBIMED ADVISORS LLC | director, 10 percent owner: | 13,981,952 | P-Purchase | A | 484,496 | 10.32 | 4,999,998.72 |
| 2022-09-14 | Novo Holdings A/S | 10 percent owner | 6,071,703 | P-Purchase | A | 484,496 | 10.32 | 4,999,998.72 |
| 2022-09-06 | MOORE JOHN R | director: General Counsel | 127,727 | M-Exempt | D | 4,730 | 0.00 | 0.00 |
| 2022-09-06 | MOORE JOHN R | director: General Counsel | 3,000 | S-Sale | D | 2,351 | 10.99 | 25,842.19 |
| 2022-08-08 | MOORE JOHN R | director: General Counsel | 200,000 | A-Award | A | 200,000 | 0.00 | 0.00 |
| 2022-08-08 | Russell Alan J | director: Chief Scientific Officer | 220,000 | A-Award | A | 220,000 | 0.00 | 0.00 |
| 2022-08-08 | Carruthers R Michael | director: Chief Financial Officer | 200,000 | A-Award | A | 200,000 | 0.00 | 0.00 |
| 2022-08-08 | Derakhshan Behrad | director: Chief Business Officer | 200,000 | A-Award | A | 200,000 | 0.00 | 0.00 |
| 2022-08-08 | Donovan Joanne M. | director: CMO | 240,000 | A-Award | A | 240,000 | 0.00 | 0.00 |
| 2022-08-08 | KOCH KEVIN | director: President and CEO | 550,000 | A-Award | A | 550,000 | 0.00 | 0.00 |
| 2022-08-03 | MOORE JOHN R | director: General Counsel | 112,558 | M-Exempt | D | 4,502 | 0.00 | 0.00 |
| 2022-08-03 | MOORE JOHN R | director: General Counsel | 3,000 | S-Sale | D | 9,232 | 9.31 | 85,921.30 |
| 2022-07-05 | MOORE JOHN R | director: General Counsel | 3,000 | S-Sale | D | 8,186 | 8.35 | 68,328.54 |
| 2022-07-05 | MOORE JOHN R | director: General Counsel | 137,187 | M-Exempt | D | 1,046 | 0.00 | 0.00 |
| 2022-06-24 | Thompson Peter A. | director: | 42,087 | A-Award | A | 42,087 | 0.00 | 0.00 |
| 2022-06-24 | ROOT JONATHAN D | director: | 42,087 | A-Award | A | 42,087 | 0.00 | 0.00 |
| 2022-06-24 | Edris Badreddin | director: | 42,087 | A-Award | A | 42,087 | 0.00 | 0.00 |
| 2022-06-24 | Brege Laura | director: | 42,087 | A-Award | A | 42,087 | 0.00 | 0.00 |
| 2022-06-16 | MOORE JOHN R | director: General Counsel | 3,000 | S-Sale | D | 31,078 | 7.29 | 226,695.36 |
| 2022-06-16 | MOORE JOHN R | director: General Counsel | 141,917 | M-Exempt | D | 17,570 | 0.00 | 0.00 |
| 2022-06-13 | MOORE JOHN R | director: General Counsel | 3,000 | S-Sale | D | 18,075 | 6.11 | 110,445.48 |
| 2022-06-13 | MOORE JOHN R | director: General Counsel | 196,336 | M-Exempt | D | 585 | 0.00 | 0.00 |
| 2022-06-08 | MOORE JOHN R | director: General Counsel | 3,000 | S-Sale | D | 7,125 | 6.05 | 43,119.79 |
| 2022-06-08 | MOORE JOHN R | director: General Counsel | 10,125 | M-Exempt | A | 7,125 | 0.71 | 5,058.75 |
| 2022-06-03 | MOORE JOHN R | director: General Counsel | 197,894 | M-Exempt | D | 13,934 | 0.00 | 0.00 |
| 2022-06-03 | MOORE JOHN R | director: General Counsel | 3,000 | S-Sale | D | 17,150 | 6.61 | 113,275.75 |
| 2022-05-23 | Carruthers R Michael | director: Chief Financial Officer | 207,122 | M-Exempt | D | 9,000 | 0.71 | 6,390.00 |
| 2022-05-18 | OrbiMed Genesis GP LLC | director: | 13,497,456 | P-Purchase | A | 138,000 | 7.21 | 994,980.00 |
| 2022-05-18 | Thompson Peter A. | director: | 13,497,456 | P-Purchase | A | 138,000 | 7.21 | 994,980.00 |
| 2022-05-16 | MOORE JOHN R | director: General Counsel | 3,000 | S-Sale | D | 10,800 | 7.42 | 80,145.72 |
| 2022-05-01 | Carruthers R Michael | director: Chief Financial Officer | 15,625 | A-Award | A | 15,625 | 0.00 | 0.00 |
| 2022-05-01 | Derakhshan Behrad | director: Chief Business Officer | 15,625 | A-Award | A | 15,625 | 0.00 | 0.00 |
| 2022-05-01 | MOORE JOHN R | director: General Counsel | 15,625 | A-Award | A | 15,625 | 0.00 | 0.00 |
| 2022-05-01 | Russell Alan J | director: Chief Scientific Officer | 15,625 | A-Award | A | 15,625 | 0.00 | 0.00 |
| 2022-05-01 | Donovan Joanne M. | director: CMO | 31,250 | A-Award | A | 31,250 | 0.00 | 0.00 |
| 2022-05-01 | KOCH KEVIN | director: President and CEO | 31,250 | A-Award | A | 31,250 | 0.00 | 0.00 |
| 2022-02-25 | ROOT JONATHAN D | director | 0 | J-Other | D | 3,473,543 | 0.00 | 0.00 |
| 2022-01-21 | MOORE JOHN R | 12,362 | M-Exempt | A | 5,400 | 0.71 | 3,834.00 | |
| 2022-01-21 | MOORE JOHN R | 205,322 | M-Exempt | D | 5,400 | 0.71 | 3,834.00 | |
| 2021-12-28 | MOORE JOHN R | 6,962 | M-Exempt | A | 5,400 | 0.71 | 3,834.00 | |
| 2021-12-28 | MOORE JOHN R | 210,722 | M-Exempt | D | 5,400 | 0.71 | 3,834.00 | |
| 2021-11-30 | Russell Alan J | 147,585 | M-Exempt | A | 147,585 | 0.18 | 26,565.30 | |
| 2021-11-30 | Russell Alan J | 172,585 | M-Exempt | A | 25,000 | 0.45 | 11,250.00 | |
| 2021-11-30 | Russell Alan J | 0 | M-Exempt | D | 147,585 | 0.18 | 26,565.30 | |
| 2021-11-30 | Russell Alan J | 130,352 | M-Exempt | D | 25,000 | 0.45 | 11,250.00 | |
| 2021-11-15 | Russell Alan J | 38 | S-Sale | D | 441 | 19.07 | 8,410.22 | |
| 2021-11-15 | Russell Alan J | 0 | S-Sale | D | 38 | 19.61 | 745.18 | |
| 2021-11-09 | Russell Alan J | 53,355 | S-Sale | D | 16,864 | 19.94 | 336,274.91 | |
| 2021-11-09 | Russell Alan J | 40,643 | S-Sale | D | 12,712 | 20.30 | 258,030.72 | |
| 2021-11-10 | Russell Alan J | 28,897 | S-Sale | D | 11,746 | 19.70 | 231,446.71 | |
| 2021-11-10 | Russell Alan J | 28,317 | S-Sale | D | 580 | 20.21 | 11,723.08 | |
| 2021-11-11 | Russell Alan J | 12,722 | S-Sale | D | 15,595 | 19.82 | 309,043.00 | |
| 2021-11-11 | Russell Alan J | 9,041 | S-Sale | D | 3,681 | 20.43 | 75,195.47 | |
| 2021-11-12 | Russell Alan J | 479 | S-Sale | D | 8,562 | 19.51 | 167,073.73 | |
| 2021-11-04 | Russell Alan J | 92,278 | S-Sale | D | 7,392 | 19.76 | 146,091.79 | |
| 2021-11-05 | Russell Alan J | 92,272 | S-Sale | D | 6 | 20.70 | 124.20 | |
| 2021-11-05 | Russell Alan J | 79,236 | S-Sale | D | 13,036 | 19.62 | 255,783.27 | |
| 2021-11-08 | Russell Alan J | 70,219 | S-Sale | D | 9,017 | 20.16 | 181,824.20 | |
| 2021-11-01 | Russell Alan J | 143,373 | S-Sale | D | 469 | 18.02 | 8,453.54 | |
| 2021-11-02 | Russell Alan J | 125,854 | S-Sale | D | 17,519 | 17.43 | 305,359.67 | |
| 2021-11-03 | Russell Alan J | 105,032 | S-Sale | D | 20,822 | 17.98 | 374,425.37 | |
| 2021-11-03 | Russell Alan J | 100,789 | S-Sale | D | 4,243 | 18.84 | 79,944.48 | |
| 2021-11-03 | Russell Alan J | 99,670 | S-Sale | D | 1,119 | 19.42 | 21,725.83 | |
| 2021-10-14 | Russell Alan J | 145,275 | S-Sale | D | 5,749 | 18.18 | 104,516.82 | |
| 2021-10-15 | Russell Alan J | 143,968 | S-Sale | D | 1,307 | 18.13 | 23,698.13 | |
| 2021-10-15 | Russell Alan J | 143,842 | S-Sale | D | 126 | 18.00 | 2,268.00 | |
| 2021-10-11 | Russell Alan J | 151,024 | S-Sale | D | 1,270 | 18.02 | 22,885.40 | |
| 2021-10-06 | Russell Alan J | 171,214 | S-Sale | D | 2,108 | 18.03 | 38,007.24 | |
| 2021-10-07 | Russell Alan J | 158,196 | S-Sale | D | 13,018 | 18.56 | 241,614.08 | |
| 2021-10-08 | Russell Alan J | 152,294 | S-Sale | D | 5,902 | 18.15 | 107,121.30 | |
| 2021-10-01 | Russell Alan J | 178,826 | S-Sale | D | 274 | 18.00 | 4,932.00 | |
| 2021-10-04 | Russell Alan J | 178,726 | S-Sale | D | 100 | 18.00 | 1,800.00 | |
| 2021-10-05 | Russell Alan J | 173,322 | S-Sale | D | 5,404 | 18.26 | 98,677.04 | |
| 2021-09-28 | Russell Alan J | 190,944 | S-Sale | D | 14,610 | 17.30 | 252,753.00 | |
| 2021-09-29 | Russell Alan J | 179,718 | S-Sale | D | 11,226 | 16.83 | 188,933.58 | |
| 2021-09-29 | Russell Alan J | 179,100 | S-Sale | D | 618 | 17.47 | 10,796.46 | |
| 2021-09-23 | Russell Alan J | 242,337 | S-Sale | D | 21,763 | 18.34 | 399,133.42 | |
| 2021-09-23 | Russell Alan J | 237,265 | S-Sale | D | 5,072 | 19.42 | 98,498.24 | |
| 2021-09-24 | Russell Alan J | 217,165 | S-Sale | D | 20,100 | 18.16 | 365,016.00 | |
| 2021-09-27 | Russell Alan J | 205,571 | S-Sale | D | 11,594 | 17.98 | 208,460.12 | |
| 2021-09-27 | Russell Alan J | 205,554 | S-Sale | D | 17 | 18.48 | 314.16 | |
| 2021-08-17 | Russell Alan J | 120,000 | A-Award | A | 120,000 | 16.38 | 1,965,600.00 | |
| 2021-08-17 | MOORE JOHN R | 120,000 | A-Award | A | 120,000 | 16.38 | 1,965,600.00 | |
| 2021-08-17 | Donovan Joanne M. | 160,000 | A-Award | A | 160,000 | 16.38 | 2,620,800.00 | |
| 2021-08-17 | Derakhshan Behrad | 140,000 | A-Award | A | 140,000 | 16.38 | 2,293,200.00 | |
| 2021-08-17 | Carruthers R Michael | 120,000 | A-Award | A | 120,000 | 16.38 | 1,965,600.00 | |
| 2021-08-17 | KOCH KEVIN | 400,000 | A-Award | A | 400,000 | 16.38 | 6,552,000.00 | |
| 2021-04-30 | Donovan Joanne M. | 160,000 | A-Award | A | 160,000 | 28.64 | 4,582,400.00 | |
| 2021-04-26 | Donovan Joanne M. | 0 | 0 | 0.00 | 0.00 | |||
| 2021-03-30 | ROOT JONATHAN D | director | 3,473,543 | C-Conversion | A | 3,473,543 | 0.00 | 0.00 |
| 2021-03-30 | ROOT JONATHAN D | director | 15,625 | P-Purchase | A | 15,625 | 16.00 | 250,000.00 |
Disclaimer: The data contained in this website is not necessarily real-time nor accurate. All derived (stocks, indexes, futures), cryptocurrencies, and Forex prices are not provided by exchanges but rather by our third party API www.financialmodellingprep.com, and so prices may not be accurate and may differ from the actual market price, meaning prices are indicative and not appropriate for trading purposes. Therefore, Discounting Cash Flows Group doesn't bear any responsibility for any trading losses you might incur as a result of using this data. Discounting Cash Flows Group or anyone involved with Discounting Cash Flows Group will not accept any liability for loss or damage as a result of reliance on the information including data, quotes, charts and buy/sell signals contained within this website. Please be fully informed regarding the risks and costs associated with trading the financial markets, it is one of the riskiest investment forms possible.